XML 30 R20.htm IDEA: XBRL DOCUMENT v3.21.2

Equity-based Compensation (Tables)

9 Months Ended

Sep. 30, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Summary of Equity Option Activity

Option activity for the nine months ended September 30, 2021 under the 2013 and 2019 Plans is as follows:

		Number of Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term				Aggregate Intrinsic Value (000's)
Balance at January 1, 2021			4,121,225			$	9.20				7.0			$	87,842
Granted			140,569				51.16				9.5
Exercised			(1,448,061	)			6.53				—
Forfeited			(42,878	)			15.69				—
Expired			(2,816	)			15.62				—
Balance at September 30, 2021			2,768,039				12.62				7.5				136,212
Exercisable at September 30, 2021			813,278				10.00				6.0				42,105
Vested and expected to vest			2,768,039				12.62				7.5				136,212

Summary of RSU Award Activity

RSU award activity for the nine months ended September 30, 2021 under the 2019 Plan is as follows:

		Class A Common Stock				Weighted Average Grant Date Fair Value				Weighted Average Remaining Contractual Term				Aggregate Intrinsic Value (000's)
Unvested at January 1, 2021			20,140			$	15.89				1.2			$	628
Granted (1)			28,224				48.16				0.5
Released			(12,742	)			15.70
Forfeited			—				—
Unvested at September 30, 2021			35,622				41.53				0.7				2,200

(1)Includes an adjustment of 11,763 shares underlying performance-based RSU awards made during the nine months ended September 30, 2021. The vesting of such RSUs is based upon the Company’s current performance against predefined financial targets.

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration